Please enable JavaScript to continue using this application.

Compare $ACET vs $KLRS | Chartloom

Compare

$ACET vs $KLRS

Adicet Bio Inc · Kalaris Therapeutics Inc

ACET

Adicet Bio Inc

KLRS

Kalaris Therapeutics Inc

Compare $ACET vs $KLRS

Comparing Adicet Bio Inc and Kalaris Therapeutics Inc

ACETAdicet Bio Inc

KLRSKalaris Therapeutics Inc

ACETAdicet Bio Inc

Market cap

$52M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-36.4%

52W performance

-62.2%

FCF yield

-162.0%

KLRSKalaris Therapeutics Inc

Market cap

$56M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-71.6%

52W performance

-64.2%

FCF yield

-73.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ACET

KLRS

Detailed metrics comparison

ACET

Adicet Bio Inc

KLRS

Kalaris Therapeutics Inc

Market Cap

ACET$52M

KLRS$56M

Enterprise Value

ACET$20M

KLRS$45M

Price

ACET$5.61

KLRS$2.36

P/E Ratio

ACETN/A

KLRSN/A

P/S Ratio

ACET1.57x

KLRS0.00x

EV/Sales

ACET0.74x

KLRS0.00x

EV/EBITDA

ACET0.00x

KLRS0.00x

P/B Ratio

ACET0.51x

KLRS1.02x

P/FCF Ratio

ACETN/A

KLRSN/A

EV/FCF

ACET-0.24x

KLRS-1.09x

PEG Ratio

ACETN/A

KLRSN/A

Forward P/E (NTM)

ACETN/A

KLRSN/A

Forward P/S (NTM)

ACETN/A

KLRSN/A

Revenue (TTM)

ACET$0

KLRS$0

Revenue Growth (YoY)

ACETN/A

KLRSN/A

Forward Rev Growth

ACET171.3%

KLRS180.3%

Gross Margin (TTM)

ACET0.0%

KLRS0.0%

Operating Margin (TTM)

ACET0.0%

KLRS0.0%

EBITDA Margin (TTM)

ACET0.0%

KLRS0.0%

Net Margin (TTM)

ACET0.0%

KLRS0.0%

FCF Margin (TTM)

ACETN/A

KLRSN/A

Net Income (TTM)

ACET$-99M

KLRS$-44M

FCF (TTM)

ACET$-85M

KLRS$-41M

EPS (TTM)

ACET-$9.21

KLRS-$1.86

ROE (TTM)

ACET-7490.0%

KLRS-7171.0%

ROA (TTM)

ACET-6087.0%

KLRS-4295.0%

ROIC (TTM)

ACET-7437.0%

KLRS-4719.0%

Cash

ACET$33M

KLRS$43M

Debt

ACET$798K

KLRS$32M

Net Cash/Debt

ACET$32M

KLRS$11M

Current Ratio (TTM)

ACET6.71x

KLRS10.98x

Quick Ratio (TTM)

ACET6.59x

KLRS10.76x

Debt/Equity (TTM)

ACET0.01x

KLRS0.56x

Debt/Assets (TTM)

ACET0.0%

KLRS0.0%

Interest Coverage (TTM)

ACETN/A

KLRSN/A

Net Debt/EBITDA (TTM)

ACET0.00x

KLRS0.00x

Beta

ACET1.68

KLRS0.44

52W Performance

ACET-62.2%

KLRS-64.2%

YTD Performance

ACET-36.4%

KLRS-71.6%

% from 52W High

ACET-67.8%

KLRS-80.1%

% from 52W Low

ACET1.1%

KLRS0.4%

Asset Turnover (TTM)

ACET0.13x

KLRS0.00x

FCF Yield (TTM)

ACET-162.0%

KLRS-73.4%

Earnings Yield (TTM)

ACET-188.7%

KLRS-78.8%

Dividend Yield (TTM)

ACETN/A

KLRSN/A

Rule of 40

ACET0.0

KLRS0.0

EV/GP/RG

ACETN/A

KLRSN/A

Ticker research

View ACET research View KLRS research

Metric	ACET Adicet Bio Inc	KLRS Kalaris Therapeutics Inc
Market & Valuation
Market Cap	$52M	$56M
Enterprise Value	$20M	$45M
Price	$5.61	$2.36
P/E Ratio	N/A	N/A
P/S Ratio	1.57x	0.00x
EV/Sales	0.74x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.51x	1.02x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.24x	-1.09x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	171.3%	180.3%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-99M	$-44M
FCF (TTM)	$-85M	$-41M
EPS (TTM)	-$9.21	-$1.86
ROE (TTM)	-7490.0%	-7171.0%
ROA (TTM)	-6087.0%	-4295.0%
ROIC (TTM)	-7437.0%	-4719.0%
Financial Health
Cash	$33M	$43M
Debt	$798K	$32M
Net Cash/Debt	$32M	$11M
Current Ratio (TTM)	6.71x	10.98x
Quick Ratio (TTM)	6.59x	10.76x
Debt/Equity (TTM)	0.01x	0.56x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.68	0.44
52W Performance	-62.2%	-64.2%
YTD Performance	-36.4%	-71.6%
% from 52W High	-67.8%	-80.1%
% from 52W Low	1.1%	0.4%
Efficiency & Yields
Asset Turnover (TTM)	0.13x	0.00x
FCF Yield (TTM)	-162.0%	-73.4%
Earnings Yield (TTM)	-188.7%	-78.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ACET research	View KLRS research

Valuation

P/S Ratio

KLRS

0.00x

ACET

1.57x

EV/FCF

KLRS

-1.09x

ACET

-0.24x

Growth & revenue

Forward Revenue Growth

KLRS

180.3%

ACET

171.3%

Profitability & performance

Gross Margin

ACET

0.0%

KLRS

0.0%

ROE

KLRS

-7171.0%

ACET

-7490.0%

FCF Yield %

KLRS

-73.4%

ACET

-162.0%

52-Week Performance

ACET

-62.2%

KLRS

-64.2%

Detailed metrics comparison

ACET

Adicet Bio Inc

KLRS

Kalaris Therapeutics Inc

Market Cap

ACET$52M

KLRS$56M

Enterprise Value

ACET$20M

KLRS$45M

Price

ACET$5.61

KLRS$2.36

P/E Ratio

ACETN/A

KLRSN/A

P/S Ratio

ACET1.57x

KLRS0.00x

EV/Sales

ACET0.74x

KLRS0.00x

EV/EBITDA

ACET0.00x

KLRS0.00x

P/B Ratio

ACET0.51x

KLRS1.02x

P/FCF Ratio

ACETN/A

KLRSN/A

EV/FCF

ACET-0.24x

KLRS-1.09x

PEG Ratio

ACETN/A

KLRSN/A

Forward P/E (NTM)

ACETN/A

KLRSN/A

Forward P/S (NTM)

ACETN/A

KLRSN/A

Revenue (TTM)

ACET$0

KLRS$0

Revenue Growth (YoY)

ACETN/A

KLRSN/A

Forward Rev Growth

ACET171.3%

KLRS180.3%

Gross Margin (TTM)

ACET0.0%

KLRS0.0%

Operating Margin (TTM)

ACET0.0%

KLRS0.0%

EBITDA Margin (TTM)

ACET0.0%

KLRS0.0%

Net Margin (TTM)

ACET0.0%

KLRS0.0%

FCF Margin (TTM)

ACETN/A

KLRSN/A

Net Income (TTM)

ACET$-99M

KLRS$-44M

FCF (TTM)

ACET$-85M

KLRS$-41M

EPS (TTM)

ACET-$9.21

KLRS-$1.86

ROE (TTM)

ACET-7490.0%

KLRS-7171.0%

ROA (TTM)

ACET-6087.0%

KLRS-4295.0%

ROIC (TTM)

ACET-7437.0%

KLRS-4719.0%

Cash

ACET$33M

KLRS$43M

Debt

ACET$798K

KLRS$32M

Net Cash/Debt

ACET$32M

KLRS$11M

Current Ratio (TTM)

ACET6.71x

KLRS10.98x

Quick Ratio (TTM)

ACET6.59x

KLRS10.76x

Debt/Equity (TTM)

ACET0.01x

KLRS0.56x

Debt/Assets (TTM)

ACET0.0%

KLRS0.0%

Interest Coverage (TTM)

ACETN/A

KLRSN/A

Net Debt/EBITDA (TTM)

ACET0.00x

KLRS0.00x

Beta

ACET1.68

KLRS0.44

52W Performance

ACET-62.2%

KLRS-64.2%

YTD Performance

ACET-36.4%

KLRS-71.6%

% from 52W High

ACET-67.8%

KLRS-80.1%

% from 52W Low

ACET1.1%

KLRS0.4%

Asset Turnover (TTM)

ACET0.13x

KLRS0.00x

FCF Yield (TTM)

ACET-162.0%

KLRS-73.4%

Earnings Yield (TTM)

ACET-188.7%

KLRS-78.8%

Dividend Yield (TTM)

ACETN/A

KLRSN/A

Rule of 40

ACET0.0

KLRS0.0

EV/GP/RG

ACETN/A

KLRSN/A

Ticker research

View ACET research View KLRS research

Metric	ACET Adicet Bio Inc	KLRS Kalaris Therapeutics Inc
Market & Valuation
Market Cap	$52M	$56M
Enterprise Value	$20M	$45M
Price	$5.61	$2.36
P/E Ratio	N/A	N/A
P/S Ratio	1.57x	0.00x
EV/Sales	0.74x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.51x	1.02x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.24x	-1.09x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	171.3%	180.3%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-99M	$-44M
FCF (TTM)	$-85M	$-41M
EPS (TTM)	-$9.21	-$1.86
ROE (TTM)	-7490.0%	-7171.0%
ROA (TTM)	-6087.0%	-4295.0%
ROIC (TTM)	-7437.0%	-4719.0%
Financial Health
Cash	$33M	$43M
Debt	$798K	$32M
Net Cash/Debt	$32M	$11M
Current Ratio (TTM)	6.71x	10.98x
Quick Ratio (TTM)	6.59x	10.76x
Debt/Equity (TTM)	0.01x	0.56x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.68	0.44
52W Performance	-62.2%	-64.2%
YTD Performance	-36.4%	-71.6%
% from 52W High	-67.8%	-80.1%
% from 52W Low	1.1%	0.4%
Efficiency & Yields
Asset Turnover (TTM)	0.13x	0.00x
FCF Yield (TTM)	-162.0%	-73.4%
Earnings Yield (TTM)	-188.7%	-78.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ACET research	View KLRS research